Role of chemotherapy of taeniasis in prevention of neurocysticercosis

Parasitology International

Volumn 55, Issue SUPPL., 2006, Pages

  Pawlowski, Zbigniew S ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

Chemotherapy; Control measures; Neurocysticercosis; Taenia solium

Indexed keywords

ANTIBIOTIC AGENT; BITHIONOL; CARBON TETRACHLORIDE; DICHLOROPHEN; HEXYLRESORCINOL; MEBENDAZOLE; MEPACRINE; NICLOSAMIDE; PAROMOMYCIN; PRAZIQUANTEL; QUININE; THYMOL;

CHEMOTHERAPY; CONFERENCE PAPER; HEALTH EDUCATION; HUMAN; NEUROCYSTICERCOSIS; POLAND; PRIORITY JOURNAL; TAENIA SOLIUM; TAENIASIS;

ANIMALS; ANTICESTODAL AGENTS; CYSTICERCUS; HUMANS; NEUROCYSTICERCOSIS; NICLOSAMIDE; PRAZIQUANTEL; TAENIA SOLIUM; TAENIASIS;

CINCHONA PUBESCENS; TAENIA; TAENIA SOLIUM;

EID: 31944444569     PISSN: 13835769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.parint.2005.11.017     Document Type: Conference Paper

References (31)

1. C. Bern, H.H. García, C. Evans, A.E. Gonzalez, M. Verastegui, and V.C.W. Tsang Magnitude of the disease burden from neurocysticercosis in a developing country Curr Infect Dis 29 1996 1203 1209
2. P.M. Schantz, P.P. Wilkins, and V.C.W. Tsang Immigrants, imaging and immunoblots: the emergence of neurocysticercosis as a significant public health problem W.M. Scheld W.A. Craig J.M. Hughes Emerging Infections vol. 2 1998 ASM Press Washington (DC) 213 242
3. M.T. Wallin, and J.F. Kurtzke Neurocysticercosis in the United States: review of an important emerging infection Neurology 63 2004 1559 1564
4. Pawlowski ZS, Allan JC, Meinardi H. Chapter 6. Control measures. In: Murrell KD, editor. Guidelines on taeniasis/cysticercosis. WHO, OIE, FAO, Geneva. 2005: 73-99.
5. B. Desta Ethiopian traditional herbal drugs: Part I. Studies on the toxicity and therapeutic activity of local taenicidal medications J Ethnopharmacol 45 1995 27 33
6. M. Gemmell, Z. Matyas, Z. Pawlowski, E.J.L. Soulsby, C. Larralde, and G.S. Nelson Guidelines for surveillance, prevention and control of taeniasis/cysticercosis 1983 WHO Geneva
7. A. Notter, J.M. Robert, and M. Bertrand Influence teratogene possible des taenifuges a base d'etain (Discussion de trois observations d'ectromelies) Bull Fed Soc Gynecol Obstet Lang Fr 20 1968 319 320 [suppl]
8. Z. Pawlowski, and M.G. Schulz Taeniasis and cysticercosis (Taenia saginata) Adv Parasitol 10 1972 269 343
9. L. Haenel Beitrag zur Toxikologie der gebrauchlichsten Anthelminthica Pharmazie 5 1950 18 23
10. J.M. Lee, T.Y. Liu, D.C. Wu, H.C. Tang, J. Leh, and M.T. Wu Safrole-DNA adducts in tissues from esophageal cancer patients: clues to areca-related esophageal carcinogenesis Mutat Res 565 2005 121 128
11. M. Fox LeAnne, and L.D. Saravolatz Nitazoxanide: a new thiazolide antiparasitic agent Clin Infect Dis 40 2005 1173 1180
12. X.W. Zhang, and Y.L. Yap Old drugs as lead compounds for a new disease? Binding analysis of SARS coronavirus main proteinase with HIV Bioorg Med Chem 15 2004 2517 2521
13. A. Flisser, I. Madrazo, A. Plancarte, P. Schantz, J. Allan, and P. Craig Neurological symptoms in occult neurocysticercosis after a single taeniacidal dose of praziquantel Lancet 342 1993 748
14. M. Cruz, A. Davis, H. Dixon, Z. Pawłowski, and J. Proano Operational studies on control of Taenia solium taeniasis/cysticercosis in Ecuador Bull WHO 67 1989 401 407
15. H. Jung, and D.F. Gonzales-Esquivel Pharmacology of anticysticercal therapy G. Singh S. Prabhar Taenia solium cysticercosis: from basic to clinical science 2002 CABI Publishing Wallingford 363 374
16. Z.S. Pawłowski Efficacy of low doses of praziquantel in taeniasis Acta Trop 48 1990 83 88
17. P.M. Schantz, M. Cruz, E. Sarti, and Z.S. Pawlowski Potential erradicability of taeniasis and cysticercosis Rev Bul Pan Am Health Org 27 1993 397 403
18. D.H. Molyneux, D.R. Hopkins, and N. Zagaria Disease eradication, elimination and control: the need for accurate and consistent usage Trends Parasitol 20 2004 347 351
19. J. Allan, P.S. Craig, and Z.S. Pawlowski Control of Taenia solium with emphasis on treatment of taeniasis G. Singh S. Prabhar Taenia solium cysticercosis: from basic to clinical science 2002 CABI Publishing Wallingford 411 420
20. D. Engels, C. Urbani, A. Belotto, F. Meslin, and L. Savioli The control of human (neuro)cysticercosis: which way forward? Acta Trop 87 2003 177 182
21. E. Sarti, and V. Rajshekhar Measures for the prevention and control of Taenia solium taeniosis and cysticercosis Acta Trop 87 2003 137 143
22. A. Ito, C. Urbani, J.M. Qiu, D.A. Vuitton, D.C. Qiu, and D.D. Health Control of echinococcosis and cysticercosis: a public health challenge to international cooperation in China Acta Trop 86 2003 3 17
23. PAHO/WHO. PAHO/WHO Informal Consultation on the Taeniosis/Cysticercosis Complex. 23-25 August, 1995, PAHO, Washington D.C.; 1995. document HCT/AIEPI-5.
24. M.L. García-Garcia, M. Tores, D. Correa, A. Flisser, A. Sosa-Lechuga, and O. Velasco Prevalence and risk of cysticercosis and taeniasis in an urban population of soldiers and their relatives Am J Trop Med Hyg 61 1999 386 389
25. A.E. Gonzalez, R.H. Gilman, H.H. Garcia, and T. Lopez Use of simulation model to evaluate control programmes against Taenia solium cysticercosis G. Singh S. Prabhar Taenia solium cysticercosis: from basic to clinical science 2002 CABI Publishing Wallingford 437 448
26. Z.S. Pawlowski Control of Taenia solium taeniasis and cysticercosis by focus-oriented chemotherapy of taeniasis Southeast Asian J Trop Med Public Health 22 1991 284 286
27. Z.S. Pawlowski, J. Allan, and E. Sarti Control of Taenia solium taeniasis/cysticercosis; from research towards implementation Int J Parasitol 35 2005 1221 1232
28. G. Roman, J. Sotelo, O. Del Brutto, A. Flisser, M. Dumas, and N. Wadia A proposal to declare neurocysticercosis an international reportable disease Bull WHO 78 2000 399 406
29. H.H. Garcia, R. Gilman, M. Martinez, V.C. Tsang, J.B. Pilcher, and G. Herrera Cysticercosis as a major cause of epilepsy in Peru Lancet 341 1993 197 200
30. A.G. Diop, H.M. de Boer, C. Mandlhate, L. Prilipko, and H. Meinardi The global campaign against epilepsy in Africa Acta Trop 87 2003 149 159
31. Presentation by Mr Bill Gates. Fifty-eighth World Health Assembly, 19th May 2005, Geneva, WHO document A58/DIV/8.